Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care—A Retrospective Cross-Sectional Study

Background: The highly β1-selective beta-blocker Landiolol is known to facilitate efficient and safe rate control in non-compensatory tachycardia or dysrhythmia when administered continuously. However, efficacy and safety data of the also-available bolus formulation in critically ill patients are sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnaubelt, Sebastian, Eibensteiner, Felix, Oppenauer, Julia, Tihanyi, Daniel, Neymayer, Marco, Brock, Roman, Kornfehl, Andrea, Veigl, Christoph, Al Jalali, Valentin, Anders, Sonja, Steinlechner, Barbara, Domanovits, Hans, Sulzgruber, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967759/
https://www.ncbi.nlm.nih.gov/pubmed/37259286
http://dx.doi.org/10.3390/ph16020134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967759/
https://www.ncbi.nlm.nih.gov/pubmed/37259286
http://dx.doi.org/10.3390/ph16020134

Ejemplares similares